Building iteration into the product commercialization process can help life sciences companies avoid many of the missteps ...

Leadership in pharma means questioning assumptions, amplifying diverse voices, and creating environments where authenticity ...

Toxicity related to the systematic delivery of IL-12, a well-known and widely researched anti-tumor cytokine, has limited its ...

AI in life sciences raises various patent law considerations, including subject matter eligibility, novelty/obviousness, and sufficiency of disclosure, explains patent attorney Noah K. Tilton.

A looming patent cliff is driving Big Pharma reorganization. Executives making career moves must understand differences in ...

Rick Modi’s background in pharmacy gave him the scientific and analytical chops to pursue an MBA and ultimately lead innovative gene therapy companies.

Sitryx CEO Iain Kilty describes the biopharmaceutical industry effort to go beyond immunosuppression in autoimmune and ...